Menendez v. Continental Ins. Co.

515 So. 2d 525, 1987 La. App. LEXIS 10450
CourtLouisiana Court of Appeal
DecidedOctober 14, 1987
DocketCA 86 0978
StatusPublished
Cited by6 cases

This text of 515 So. 2d 525 (Menendez v. Continental Ins. Co.) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Menendez v. Continental Ins. Co., 515 So. 2d 525, 1987 La. App. LEXIS 10450 (La. Ct. App. 1987).

Opinion

515 So.2d 525 (1987)

Mary MENENDEZ
v.
CONTINENTAL INSURANCE COMPANY.

No. CA 86 0978.

Court of Appeal of Louisiana, First Circuit.

October 14, 1987.
Rehearing Denied December 11, 1987.
Stay Order Denied; Writ Denied January 15, 1988.

*526 C. John Caskey, Baton Rouge, for plaintiff-appellant Mary Menendez.

Arthur Cobb, Baton Rouge, in pro. per.

Mary H. Thompson, Baton Rouge, for defendant-appellee Continental Ins. Co.

Before LOTTINGER, EDWARDS and ALFORD, JJ.

LOTTINGER, Judge.

In this worker's compensation proceeding, plaintiff, Dr. Mary Menendez, appeals a finding by the trial court that her present allergic condition to things in the environment was not triggered by a medication prescribed to her following her accident at work. The trial court found in favor of the defendant Continental Insurance Company and intervenor Arthur Cobb.

FACTS

Plaintiff sustained a work-related injury April 21, 1981, when she fell down the steps during the course and scope of her employment on the Baton Rouge campus of Louisiana State University. Plaintiff has been unable to work since that time and had back surgery by Dr. Ralph Rashbaum September 12, 1983. On October 5, 1983, Dr. Rashbaum prescribed Tylenol III and Motrin. Upon realizing the prescription was for Motrin, she attempted to have Dr. Rashbaum change it because Motrin upsets her gastrointestinal tract. His assistant, Jim McKenney, substituted the Motrin prescription with two to four sample bottles of Feldene. The label on the sample bottle of Feldene introduced into evidence read, "One Week's Supply, 7 Capsules," and "Usual Dosage: One Capsule per Day." The plaintiff testified she thought she had taken the Feldene four times a day. Within two and one-half weeks, she experienced numbness and tingling in her face and hands, nausea, dizziness, burning in the lower back, legs and underarms, and spontaneous bruising the size of lemons. On or about October 26, 1983, she called Dr. Rashbaum, who was unavailable, to report the adverse reaction. His assistant called back and explained Dr. Rashbaum wanted *527 her to continue taking the Feldene. She followed the advice, but her condition worsened. On or about November 6, she stopped taking the Feldene on her own. When her symptoms showed no improvement and she additionally began to experience "racing" sensations, she sought help from Dr. Alfred Johnson, who admitted her November 18 to the environmental isolation unit at the Northeast Community Hospital in Dallas, Texas.

Dr. Johnson testified he believed the Feldene was a "triggering" agent that "sensitized" plaintiff to many things in her environment, including formaldehyde found in carpet, cigarette smoke, and such foods as carrots, sweet potatoes, chicken, walnuts, rice, beef, eggs, certain fruits, kidney beans, soy, red snapper, salmon, shrimp and flounder. Dr. Johnson was accepted as an expert in the field of osteopathic medicine, internal medicine, allergy, ecology, and environmental medicine.

Testimony also revealed plaintiff had not had such sensitivities before taking the Feldene. However, in 1978, or 1979, she had experienced a reaction similar to the one she had with Feldene when she was given a drug following surgery. She could not recall the name of the drug, but like Feldene, she said it too was an anti-inflammatory. The symptoms stopped within a few days after she stopped taking the drug. While the "acute" reaction to the Feldene ended during her three-week hospital stay, she testified she is now "hypersensitive" and cannot get too near such things as detergents in supermarkets without fainting.

Dr. Johnson testified plaintiff's treatment consists of avoiding those things to which she tested positive. He also prescribed vitamins and minerals, and antigen injections to strengthen her immune system. Tests showed plaintiff had a low IGA (immune globulin A deficiency). Plaintiff discontinued the injections due to their cost.

Defendant paid for the three-week hospital stay and Dr. Johnson's initial evaluation, but refused to pay any further bills related to plaintiff's allergic condition.

Dr. Johnson testified plaintiff still suffers from her back pain, and her allergic condition confines her to her home. He stated her prognosis for a full orthopedic recovery would be enhanced if she could follow the prescribed immunotherapy.

Defendant offered the testimony of Dr. Ronald E. Gots, an M.D. and a Ph.D. in pharmacology with an emphasis in both pharmacology and toxicology. Dr. Gots was accepted as an expert in the field of pharmacology and toxicology. Dr. Gots was critical of Dr. Johnson and his treatments because he did not think clinical ecology was a scientific practice. Although Dr. Gots thought plaintiff probably suffered an adverse reaction to the Feldene initially, he doubted she had the hypersensitive condition described by Dr. Johnson. He opined, "Feldene could not have caused [a hypersensitive condition] because it doesn't exist. But, besides that, even if there were such a thing as a panallergic phenomena of some sort, there is no indication anywhere in the literature of the world that Feldene is an incitor of such a disorder." Dr. Gots conceded he never saw nor examined plaintiff.

TRIAL COURT

The trial court denied recovery, concluding that plaintiff's allergic reaction was "not in the nature of natural, foreseeable and expected consequences of the plaintiff's work-related injury." The trial court was particularly persuaded by Dr. Gots that "there is no precedent or scientific basis for the allegation that the anti-inflammatory medication taken by the plaintiff could in any way produce the allergic reaction or sensitivities to environmental factors as alleged."

ASSIGNMENTS OF ERROR

In appealing, plaintiff-appellant contends the trial court erred (1) in holding the drug reaction must be a foreseeable and expected consequence of plaintiff's work-related injury, and (2) in failing to accord deferential weight to the testimony of plaintiff's treating physician as opposed to the testimony of defendant's expert.

*528 ASSIGNMENT OF ERROR NO. 1

It is well settled a worker's compensation claimant's disability is presumed to result from an accident, if before the accident claimant was in good health and commencing with the accident, the symptoms of the disabling condition appear and continuously manifest themselves afterwards, provided the medical evidence shows a reasonable possibility of causal connection between the accident and the disabling condition. Hammond v. Fidelity & Casualty Co. of New York, 419 So.2d 829 (La.1982).

Defendant argues if there is an intervening cause, there is no liability for compensation beyond the disability produced by the job-connected accident. But when there is no intervening cause, it is presumed the accident caused the disability. Haughton v. Fireman's Fund American Ins. Companies, 355 So.2d 927 (La.1978). Here, there is no evidence of an intervening cause. Thus, the presumption applies and the burden shifted to the defendant, who failed to prove the accident did not cause the disability.

Thus, assuming arguendo, the dosage of Feldene taken by plaintiff caused an adverse reaction, and this adverse reaction so "sensitized" plaintiff as to cause her to have allergic reactions to things in her environment, the question then becomes whether the trial court was correct in requiring such a condition be in the nature of natural, foreseeable, and expected consequences of plaintiff's work-related injury.

This court, in

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dean v. K-Mart Corp.
720 So. 2d 349 (Louisiana Court of Appeal, 1998)
Latiolais v. Emile Barras, Inc.
651 So. 2d 409 (Louisiana Court of Appeal, 1995)
Durham Pontiac-Cadillac-GMC Trucks, Inc. v. Phillips
572 So. 2d 1080 (Louisiana Court of Appeal, 1990)
Kirt v. Oaklawn Sugar Co.
555 So. 2d 999 (Louisiana Court of Appeal, 1989)
Carmouche v. Cna Insurance Companies
535 So. 2d 1279 (Louisiana Court of Appeal, 1988)
Menendez v. Continental Insurance Co.
517 So. 2d 808 (Supreme Court of Louisiana, 1988)

Cite This Page — Counsel Stack

Bluebook (online)
515 So. 2d 525, 1987 La. App. LEXIS 10450, Counsel Stack Legal Research, https://law.counselstack.com/opinion/menendez-v-continental-ins-co-lactapp-1987.